We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology and inflammation. Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca and Ono Pharmaceutical.

Employee Rating

HQPrinceton, US
Size (employees)2,100 (est)+75%
Evotec was founded in 1993 and is headquartered in Princeton, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Evotec

Werner Lanthaler

Werner Lanthaler

Mario Polywka

Mario Polywka

Cord Dohrmann

Cord Dohrmann

Show more

Evotec Office Locations

Evotec has offices in Princeton, Hamburg, South San Francisco, Branford and in 8 other locations
Princeton, US (HQ)
303 College Rd E
Hamburg, DE (HQ)
7 Essener Bogen
Branford, US
6 33 Business Park Dr
Princeton, US
3 College Rd E
South San Francisco, US
1 385 Oyster Point Blvd
Toulouse, FR
195 Route d'Espagne
Show all (13)
Report incorrect company information

Evotec Financials and Metrics

Evotec Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
AptuitJuly 30, 2017$300 m
Report incorrect company information

Evotec Online and Social Media Presence

Embed Graph
Report incorrect company information

Evotec News and Updates

Haplogens novel antiviral target partnered with Evotec published in 'Nature'

Vienna/Amsterdam/Hamburg, 12 January 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced a promising research result in the field of picornaviruses published in a scientific article by Dr Thijn Brummelkamp, the co-founder of Haplogen GmbH ("Haplogen"), a biote…

Evotec and CHDI Foundation extend ongoing collaboration to fight Huntingtons disease

The collaboration was initiated in 2006 and has grown considerably over this period to fully utilise Evotec’s best-in-class integrated neuroscience platform. The extension of this collaboration is a further validation of Evotec’s investment in new technologies and capabilities in support of driving …

In-Vitro Toxicology Market, 2018-2023 by Technology, Method, Products and Services

DUBLIN, July 26, 2018 /PRNewswire/ -- The "In Vitro Toxicology Market" report has been added to ResearchAndMarkets.com's offering. The in vitro toxicity testing markets include methods and technologies used for toxicity testing of pharmaceuticals, cosmetics, chemicals and food ingredients ...
Show more
Report incorrect company information

Evotec Company Life and Culture

Report incorrect company information

Evotec Frequently Asked Questions

  • When was Evotec founded?

    Evotec was founded in 1993.

  • Who are Evotec key executives?

    Evotec's key executives are Werner Lanthaler, Mario Polywka and Cord Dohrmann.

  • How many employees does Evotec have?

    Evotec has 2,100 employees.

  • Who are Evotec competitors?

    Competitors of Evotec include MyoKardia, Reata Pharmaceuticals and Shire.

  • Where is Evotec headquarters?

    Evotec headquarters is located at 303 College Rd E, Princeton.

  • Where are Evotec offices?

    Evotec has offices in Princeton, Hamburg, South San Francisco, Branford and in 8 other locations.

  • How many offices does Evotec have?

    Evotec has 13 offices.